Encontrados 30 documentos, a visualizar página 1 de 3
Biosensors for natriuretic peptides in cardiovascular diseases. A review
Sousa, MP; Bettencourt P; Brás-Silva C; Pereira, CHeart failure (HF) is a complex clinical syndrome associated with high rates of morbidity and mortality. Over the years, it has been crucial to find accurate biomarkers capable of doing a precise monitor of HF and provide an early diagnosis. Of these, it has been established an important role of natriuretic peptides in HF assessment. Moreover, the development of biosensors has been garnering interest as new dia...
Cardiovascular effects of relaxin-2: therapeutic potential and future perspectives
Almeida-Pinto, N; Dschietzig, TB; Brás-Silva C; Adao, RThe hormone relaxin-2 has emerged as a promising player in regulating the physiology of the cardiovascular system. Through binding to the relaxin family peptide receptor 1 (RXFP1), this hormone elicits multiple physiological responses including vasodilation induction, reduction of inflammation and oxidative stress, and angiogenesis stimulation. The role of relaxin-2, or its recombinant human form known as serel...
Physiological and pathophysiological roles of the KCNK3 potassium channel in th...
Willer, ASM; Santos Gomes, J; Adao, R; Brás-Silva C; Eyries, M; Perez Vizcaino, F; Capuano, V; Montani, D; Antigny, FPotassium channel subfamily K member 3 (KCNK3), encoded by the KCNK3 gene, is part of the two-pore domain potassium channel family, constitutively active at resting membrane potentials in excitable cells, including smooth muscle and cardiac cells. Several physiological and pharmacological mediators, such as intracellular signalling pathways, extracellular pH, hypoxia and anaesthetics, regulate KCNK3 channel fun...
Pulmonary Valve Replacement: A New Paradigm with Tissue Engineering
Almeida-Pintoa, R; Leite-Moreira AF; Brás-Silva C; Adao, RPrevalence of congenital heart diseases worldwide is around 9 per 1000 newborns, 20% of which affect the pulmonary valve or right ventricular outflow tract. As survival after surgical repair of these defects has improved over time, there is the need to address the long-term issues of older children and young adults with repaired congenital heart dis-eases. In recent decades, the most used types of valves are th...
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
Vaz Salvador, P; Adao, R; Vasconcelos, I; Leite-Moreira AF; Brás-Silva CWhile guidelines for management of heart failure with reduced ejection fraction (HFrEF) are consensual and have led to improved survival, treatment options for heart failure with preserved ejection fraction (HFpEF) remain limited and aim primarily for symptom relief and improvement of quality of life. Due to the shortage of therapeutic options, several drugs have been investigated in multiple clinical trials. T...
Therapeutic Approaches in Pulmonary Arterial Hypertension with Beneficial Effec...
Balsa, A; Adao, R; Brás-Silva CPulmonary hypertension (PH) is a progressive condition that affects the pulmonary vessels, but its main prognostic factor is the right ventricle (RV) function. Many mice/rat models are used for research in PAH, but results fail to translate to clinical trials. This study reviews studies that test interventions on pulmonary artery banding (PAB), a model of isolated RV disfunction, and PH models. Multiple tested ...
Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental p...
Adao, R; Mendes Ferreira, P; Maia Rocha, C; Santos Ribeiro, D; Rodrigues, PG; Vidal Meireles, A; Monteiro Pinto, C; Pimentel, LD; Falcao Pires, IWe have previously shown that treatment with recombinant human neuregulin-1 (rhNRG-1) improves pulmonary arterial hypertension (PAH) in a monocrotaline (MCT)-induced animal model, by decreasing pulmonary arterial remodelling and endothelial dysfunction, as well as by restoring right ventricular (RV) function. Additionally, rhNRG-1 treatment showed direct myocardial anti-remodelling effects in a model of pressur...
Update on pathophysiology and preventive strategies of anthracycline-induced ca...
Corremans, R; Adao, R; De Keulenaer, GW; Leite Moreira, AF; Brás-Silva CAnthracycline chemotherapy has a prominent role in treating many forms of cancer. Unfortunately, cardiotoxic side effects represent a serious limitation to their use, with doxorubicin being the leading drug of the group. Indeed, anthracycline-induced cardiomyopathy is an important public health concern because it may not be detected for many years and remains a lifelong threat. Even after decades of investigati...
Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Ar...
Hautefort, A; Mendes Ferreira, P; Sabourin, J; Manaud, G; Bertero, T; Rucker Martin, C; Riou, M; Adao, R; Manoury, B; Lambert, M; Boet, A; Lecerf, FBACKGROUND: Monoallelic mutations in the gene encoding bone morphogenetic protein receptor 2 (Bmpr2) are the main genetic risk factor for heritable pulmonary arterial hypertension (PAH) with incomplete penetrance. Several Bmpr2 transgenic mice have been reported to develop mild spontaneous PAH. In this study, we examined whether rats with the Bmpr2 mutation were susceptible to developing more severe PAH. METHOD...
Improvement in left intraventricular pressure gradients after aortic valve repl...
Guerra, M; Mendes Ferreira, P; Adao, R; Pereira, E; Vieira, M; Lourenco, AP; Brás-Silva C; Bastos, P; Vouga, L; Leite Moreira, AFNew Findings: What is the central question of this study? Normal diastolic and systolic intraventricular pressure gradients are decreased when left ventricular filling and/or emptying are compromised. We hypothesized that in patients with severe aortic valve stenosis, a condition that interferes with ventricular filling and emptying, those gradients would be disturbed. What is the main finding and its importanc...